Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer.

NCT05594082 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05594082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05594082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness and Safety Study of T-Dxd in Chinese Metastatic Breast Cancer.
Lead sponsor
Fudan University
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2021
Completion date
July 1, 2024
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer